TIERNEY SHEA

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant LAS VEGAS, NV NPI 1952829582

General Payments — all program years on this page

$2,079.65

  • Category: General Payments
  • Program years: PY2021–2022
  • Record count: 123
  • As of (CMS publication): 2026-01-23

Latest program year (PY2022): $376.47 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2022) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $376.4720

By paying entity

Latest program year (PY2022) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $1,703.18103
2022 $376.4720

Records — PY2022 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
887759683 Boehringer Ingelheim Pharmaceuticals, Inc. $28.86 06/07/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
887759685 Boehringer Ingelheim Pharmaceuticals, Inc. $34.65 05/23/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
887759687 Boehringer Ingelheim Pharmaceuticals, Inc. $32.74 02/28/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
887759689 Boehringer Ingelheim Pharmaceuticals, Inc. $16.88 01/13/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
894167493 ABBVIE INC. $25.42 03/01/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
894830989 Novartis Pharmaceuticals Corporation $17.28 05/16/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
898939829 Novo Nordisk Inc $15.07 05/12/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
899038069 Novo Nordisk Inc $13.96 03/02/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
899038077 Novo Nordisk Inc $15.92 04/06/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
899084439 Novo Nordisk Inc $14.44 01/03/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
899449941 Novo Nordisk Inc $18.97 02/08/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
918746159 Lilly USA, LLC $14.42 04/26/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
920660361 Abbott Laboratories $14.11 03/23/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
930538473 Bayer HealthCare Pharmaceuticals Inc. $16.64 01/25/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
940104571 Astellas Pharma US Inc $18.71 01/19/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
944810063 GlaxoSmithKline, LLC. $16.73 04/28/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
946530565 Xeris Pharmaceuticals, Inc. $18.26 04/20/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
949510181 PFIZER INC. $16.13 05/26/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
956180043 Takeda Pharmaceuticals U.S.A., Inc. $11.90 02/03/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
959921611 Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.38 07/06/2022 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.